{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T22:57:19Z","timestamp":1793141839963,"version":"4.5.0"},"reference-count":27,"publisher":"American Medical Association (AMA)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Ophthalmol"],"published-print":{"date-parts":[[2020,3,1]]},"DOI":"10.1001\/jamaophthalmol.2019.5710","type":"journal-article","created":{"date-parts":[[2020,1,16]],"date-time":"2020-01-16T16:31:56Z","timestamp":1579192316000},"page":"260","source":"Crossref","is-referenced-by-count":50,"title":["Accuracy of The Cancer Genome Atlas Classification vs American Joint Committee on Cancer Classification for Prediction of Metastasis in Patients With Uveal Melanoma"],"prefix":"10.1001","volume":"138","author":[{"given":"Mehdi","family":"Mazloumi","sequence":"first","affiliation":[{"name":"Ocular Oncology Service, Wills Eye Hospital, Thomas Jefferson University, Philadelphia, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pornpattana","family":"Vichitvejpaisal","sequence":"additional","affiliation":[{"name":"Ocular Oncology Service, Wills Eye Hospital, Thomas Jefferson University, Philadelphia, Pennsylvania"},{"name":"Chulabhorn Hospital, HRH Princess Chulabhorn College of Medical Science, Chulabhorn Royal Academy, Bangkok, Thailand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren A.","family":"Dalvin","sequence":"additional","affiliation":[{"name":"Ocular Oncology Service, Wills Eye Hospital, Thomas Jefferson University, Philadelphia, Pennsylvania"},{"name":"Department of Ophthalmology, Mayo Clinic, Rochester, Minnesota"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Yaghy","sequence":"additional","affiliation":[{"name":"Ocular Oncology Service, Wills Eye Hospital, Thomas Jefferson University, Philadelphia, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathryn G.","family":"Ewens","sequence":"additional","affiliation":[{"name":"Perelman School of Medicine, Department of Genetics, University of Pennsylvania, Philadelphia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arupa","family":"Ganguly","sequence":"additional","affiliation":[{"name":"Perelman School of Medicine, Department of Genetics, University of Pennsylvania, Philadelphia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carol L.","family":"Shields","sequence":"additional","affiliation":[{"name":"Ocular Oncology Service, Wills Eye Hospital, Thomas Jefferson University, Philadelphia, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"2","key":"eoi190095r1","first-page":"186","article-title":"Uveal melanoma treatment and prognostication.","volume":"6","author":"Dogrus\u00f6z","year":"2017","journal-title":"Asia Pac J Ophthalmol (Phila)"},{"issue":"4","key":"eoi190095r2","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1016\/j.ophtha.2018.09.031","article-title":"Understanding uveal melanoma metastasis to the liver: the Zimmerman effect and the Zimmerman hypothesis.","volume":"126","author":"Grossniklaus","year":"2019","journal-title":"Ophthalmology"},{"issue":"2","key":"eoi190095r3","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/j.ophtha.2017.08.017","article-title":"Adjuvant sunitinib in high-risk patients with uveal melanoma: comparison with institutional controls.","volume":"125","author":"Valsecchi","year":"2018","journal-title":"Ophthalmology"},{"issue":"10","key":"eoi190095r4","doi-asserted-by":"publisher","first-page":"2265","DOI":"10.1016\/j.ophtha.2016.06.027","article-title":"Adjuvant dendritic cell vaccination in high-risk uveal melanoma.","volume":"123","author":"Bol","year":"2016","journal-title":"Ophthalmology"},{"issue":"12","key":"eoi190095r5","first-page":"6541","article-title":"Clinical, histopathological and cytogenetic prognosticators in uveal melanoma\u2014a comprehensive review.","volume":"37","author":"Berus","year":"2017","journal-title":"Anticancer Res"},{"issue":"9010","key":"eoi190095r6","doi-asserted-by":"publisher","first-page":"1222","DOI":"10.1016\/S0140-6736(96)90736-9","article-title":"Prognostic implications of monosomy 3 in uveal melanoma.","volume":"347","author":"Prescher","year":"1996","journal-title":"Lancet"},{"issue":"3","key":"eoi190095r7","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.1167\/iovs.02-0159","article-title":"Monosomy 3 in uveal melanoma: correlation with clinical and histologic predictors of survival.","volume":"44","author":"Scholes","year":"2003","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"10","key":"eoi190095r8","doi-asserted-by":"publisher","first-page":"1523","DOI":"10.1016\/j.ophtha.2017.04.003","article-title":"Personalized prognosis of uveal melanoma based on cytogenetic profile in 1059 patients over an 8-year period: the 2017 Harry S. Gradle lecture.","volume":"124","author":"Shields","year":"2017","journal-title":"Ophthalmology"},{"issue":"20","key":"eoi190095r9","doi-asserted-by":"publisher","first-page":"7205","DOI":"10.1158\/0008-5472.CAN-04-1750","article-title":"Gene expression profiling in uveal melanoma reveals two molecular classes and predicts metastatic death.","volume":"64","author":"Onken","year":"2004","journal-title":"Cancer Res"},{"key":"eoi190095r10","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.ajo.2018.07.045","article-title":"Gene expression profiling and PRAME status versus tumor-node-metastasis staging for prognostication in uveal melanoma.","volume":"195","author":"Cai","year":"2018","journal-title":"Am J Ophthalmol"},{"issue":"2","key":"eoi190095r11","doi-asserted-by":"publisher","first-page":"93","DOI":"10.3322\/caac.21388","article-title":"The Eighth Edition AJCC Cancer Staging Manual: Continuing to build a bridge from a population-based to a more \u201cpersonalized\u201d approach to cancer staging.","volume":"67","author":"Amin","year":"2017","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"eoi190095r13","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1007\/s12253-017-0355-7","article-title":"The results of stricter inclusion criteria in an immunomagnetic detection study of micrometastatic cells in bone marrow of uveal melanoma patients\u2014relevance for dormancy.","volume":"25","author":"Eide","year":"2019","journal-title":"Pathol Oncol Res"},{"issue":"10","key":"eoi190095r14","doi-asserted-by":"publisher","first-page":"1925","DOI":"10.1016\/j.ophtha.2007.06.012","article-title":"Cytogenetics of uveal melanoma: a 7-year clinical experience.","volume":"114","author":"Damato","year":"2007","journal-title":"Ophthalmology"},{"issue":"3","key":"eoi190095r15","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1001\/archopht.126.3.416","article-title":"Role of cytogenetics in management of uveal melanoma.","volume":"126","author":"Shields","year":"2008","journal-title":"Arch Ophthalmol"},{"issue":"5","key":"eoi190095r16","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1016\/j.ophtha.2016.12.026","article-title":"Cytogenetic abnormalities in uveal melanoma based on tumor features and size in 1059 patients: the 2016 W. Richard Green lecture.","volume":"124","author":"Shields","year":"2017","journal-title":"Ophthalmology"},{"issue":"1","key":"eoi190095r17","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1504\/IJBET.2012.045355","article-title":"Enhancing survival prognostication in patients with choroidal melanoma by integrating pathologic, clinical and genetic predictors of metastasis.","volume":"8","author":"Eleuteri","year":"2012","journal-title":"Int J Biomed Eng Technol"},{"issue":"1","key":"eoi190095r18","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1167\/iovs.14-15571","article-title":"The prognostic effect of American Joint Committee on Cancer staging and genetic status in patients with choroidal and ciliary body melanoma.","volume":"56","author":"Bagger","year":"2014","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"10","key":"eoi190095r19","doi-asserted-by":"publisher","first-page":"4096","DOI":"10.1167\/iovs.17-22255","article-title":"PRiMeUM: a model for predicting risk of metastasis in uveal melanoma.","volume":"58","author":"Vaquero-Garcia","year":"2017","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"24","key":"eoi190095r20","doi-asserted-by":"publisher","first-page":"6083","DOI":"10.1158\/1078-0432.CCR-10-2076","article-title":"Genotypic profiling of 452 choroidal melanomas with multiplex ligation-dependent probe amplification.","volume":"16","author":"Damato","year":"2010","journal-title":"Clin Cancer Res"},{"issue":"1","key":"eoi190095r21","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.ccell.2017.12.013","article-title":"Integrative analysis identifies four molecular and clinical subsets in uveal melanoma.","volume":"33","author":"Robertson","year":"2018","journal-title":"Cancer Cell"},{"issue":"8","key":"eoi190095r22","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1016\/j.ophtha.2018.03.011","article-title":"The Cancer Genome Atlas Project: an integrated molecular view of uveal melanoma.","volume":"125","author":"Jager","year":"2018","journal-title":"Ophthalmology"},{"issue":"10","key":"eoi190095r23","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1016\/j.ophtha.2019.04.027","article-title":"Genetic analysis of uveal melanoma in 658 patients using The Cancer Genome Atlas classification of uveal melanoma as A, B, C, and D.","volume":"126","author":"Vichitvejpaisal","year":"2019","journal-title":"Ophthalmology"},{"issue":"8","key":"eoi190095r24","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1001\/archophthalmol.2009.208","article-title":"Metastasis of uveal melanoma millimeter-by-millimeter in 8033 consecutive eyes.","volume":"127","author":"Shields","year":"2009","journal-title":"Arch Ophthalmol"},{"issue":"9","key":"eoi190095r25","doi-asserted-by":"publisher","first-page":"3335","DOI":"10.1167\/iovs.16-20465","article-title":"Comparison of alternative tumor size classifications for posterior uveal melanomas.","volume":"58","author":"Skinner","year":"2017","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"10","key":"eoi190095r26","doi-asserted-by":"publisher","first-page":"1778","DOI":"10.1016\/j.ophtha.2008.04.025","article-title":"Routes of extraocular extension of uveal melanoma: risk factors and influence on survival probability.","volume":"115","author":"Coupland","year":"2008","journal-title":"Ophthalmology"},{"issue":"12","key":"eoi190095r27","doi-asserted-by":"publisher","first-page":"2152","DOI":"10.1038\/eye.2009.235","article-title":"A reappraisal of the significance of largest basal diameter of posterior uveal melanoma.","volume":"23","author":"Damato","year":"2009","journal-title":"Eye (Lond)"},{"key":"eoi190095r12","doi-asserted-by":"crossref","DOI":"10.1007\/978-3-319-40618-3","volume-title":"AJCC Cancer Staging Manual","author":"Amin","year":"2017","edition":"8th ed"}],"container-title":["JAMA Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamaophthalmology\/articlepdf\/2758934\/jamaophthalmology_mazloumi_2020_oi_190095.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,3,12]],"date-time":"2020-03-12T15:01:01Z","timestamp":1584025261000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamaophthalmology\/fullarticle\/2758934"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,1]]},"references-count":27,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,3,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamaophthalmol.2019.5710","relation":{},"ISSN":["2168-6165"],"issn-type":[{"value":"2168-6165","type":"print"}],"subject":[],"published":{"date-parts":[[2020,3,1]]}}}